AXS Stock Recent News

PEMBROKE, Bermuda--(BUSINESS WIRE)---- $AXS #insurance--AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) today announced that it expects to release financial results for the first quarter ended March 31, 2025 on Wednesday, April 30, 2025 after the close of the financial markets. Vince Tizzio, President and Chief Executive Officer, and Peter Vogt, Chief Financial Officer, will host an investor teleconference, including a question and answer period, on Thursday, May 1, 2025 at 8:30 a.m. ET.

Axsome's AXS-05 shows strong efficacy in treating Alzheimer's Disease Agitation, with significant CMAI score reductions in multiple Phase 3 trials. The FDA has greenlit Axsome to submit an sNDA for AXS-05 without requiring new trials, based on robust existing data. AXS-05 demonstrates a favorable safety profile with low discontinuation rates due to adverse events, unlike competitors such as AVP-786 and brexpiprazole.

AXIS Capital gains from a well-performing specialty insurance, reinsurance as well as the accident and health portfolio.

Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?

London, United Kingdom--(Newsfile Corp. - February 25, 2025) - Edison issues report on Accsys Technologies (AIM: AXS). At its investor strategy day, Accsys set financial targets for the coming years, with a combined volume and revenue CAGR of 14% for FY25-30e for the plant in the Netherlands and the Accoya USA plant (60%/40% joint venture (JV)).

AXIS Capital stock is poised to gain from a well-performing specialty insurance, reinsurance as well as the accident and health portfolio.

Axsome Therapeutics, Inc.'s stock has surged over 30% since my last “Hold” rating, driven by key catalysts like the litigation settlement with Teva Pharmaceuticals, announced today. Axsome's Auvelity and Sunosi are crucial, with Auvelity expected to generate over 75% of 2025 revenues; as such, today's news is a significant win. Despite high competition in MDD and other markets, Axsome's pipeline, including AXS-07 and AXS-12, shows potential for substantial revenue growth.

AXIS Capital Holdings Limited (NYSE:AXS ) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Cliff Gallant - Head, Investor Relations Vince Tizzio - President and Chief Executive Officer Pete Vogt - Chief Financial Officer Conference Call Participants Andrew Kligerman - TD Securities Yaron Kinar - Jefferies Brian Meredith - UBS Josh Shanker - Bank of America Charlie Lederer - BMO Operator Good morning, and welcome to the AXIS Capital Fourth Quarter 2024 Conference Call. All participants will be in a listen-only mode.

AXS' fourth-quarter results reflect improved net investment income and higher premiums, offset by higher expenses.

While the top- and bottom-line numbers for Axis Capital (AXS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.